The safety of double-and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study

Gary J. Weil, Joshua Bogus, Michael Christian, Christine Dubray, Yenny Djuardi, Peter U. Fischer, Charles W. Goss, Myra Hardy, Purushothaman Jambulingam, Christopher L. King, Vijesh Sridhar Kuttiat, Kaliannagounder Krishnamoorthy, Moses Laman, Jean Frantz Lemoine, Katiuscia K. O’brian, Leanne J. Robinson, Josaia Samuela, Kenneth B. Schechtman, Anita Sircar, Adinarayanan SrividyaAndrew C. Steer, Taniawati Supali, Swaminathan Subramanian

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'The safety of double-and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study'. Together they form a unique fingerprint.

Medicine & Life Sciences